Keval Patel, MD
Internal Medicine · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 21
- 5 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Community Memorial Hospital - Ventura · Contra Costa Regional Medical Center · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
21 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Patel’s office at (408) 767-8632 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
21 of 21 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- Illinois 036092912Licensed Physician And Surgeon · since 1996 · expires 2017-07-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Memorial Hospital - VenturaVentura, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Memorial Health System, which runs 2 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.478, Oct 2024 – Sep 2025
- Contra Costa Regional Medical CenterMartinez, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Contra Costa Health ServicesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.167, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Memorial Hospital - Ventura
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.478 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.95) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.49 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.27 (93.9 to 200.65) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 86 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 120 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 273 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 363 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,592 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 5,727 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 5,976 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.6 (1.57 to 5.64) · 1,733 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 688 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.97 (1.53 to 4.4) · 1,669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.87 (1.2 to 14.54) · 661 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.35 to 8.61) · 686 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 327 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.93) · 3,678 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 218 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.548 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.157 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.228 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 249 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 649 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.8 · 157 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -40.6 · 357 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 619 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 8) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (6.1 to 13) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 164 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.2 (8.7 to 14.7) · 1,178 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 986 cases | No different | Jan 2024 – Dec 2024 |
What patients said (949 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Contra Costa Regional Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 1 better, 4 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.167 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.04) · 188 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.63 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 321 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,181 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,198 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (0.67 to 5.72) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 195 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.36 (1.01 to 19.71) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.08) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.58) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.93 (0 to 2.03) · 981 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.948 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.027 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 101 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 52.2 · 126 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -53.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.6) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (8.8 to 17.8) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 35 cases | None | Jul 2023 – Jun 2025 |
What patients said (521 patients answered, 10% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$70,060
Medicare paid this office $70,060 for 102 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 65 | $22,332 | $67 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 11 | $19,845 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 73 | $9,788 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $7,745 | $99 |
| Return visit (30+ min) | 14 | $5,510 | $87 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 19 | More than 68% of doctors who do this |
Who their Medicare patients are
102 Original Medicare patients in 2024. Average age 77 · 85 and older 28% · Women 44% · Also on Medicaid 36% · Health risk score 3.93. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 63% · Heart failure 62% · Coronary heart disease 60% · Chronic kidney disease 57% · Atrial fibrillation 52% · Dementia 41% · COPD 36% · Depression 35% · Cancer 18% · Stroke 16%.
The office billed $198,350, Medicare allowed $90,160 and paid $70,060; for 834 services of 17 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 102 | 834 | 77 | 3.93 | $198,350 | $70,060 |
| 2023 | 153 | 1,618 | 76 | 3.37 | $354,895 | $134,303 |
| 2022 | 132 | 1,298 | 76 | 3.02 | $288,250 | $123,342 |
| 2021 | 79 | 1,016 | 75 | 2.61 | $234,755 | $95,191 |
| 2020 | 83 | 926 | 76 | 2.96 | $203,755 | $71,691 |
| 2019 | 94 | 1,055 | 76 | 2.90 | $212,910 | $65,818 |
| 2018 | 206 | 2,211 | 76 | 2.64 | $444,948 | $130,577 |
| 2017 | 176 | 1,754 | 74 | 2.66 | $338,524 | $93,972 |
| 2016 | 266 | 2,146 | 75 | 2.57 | $461,150 | $131,744 |
| 2015 | 620 | 4,751 | 74 | 2.17 | $587,412 | $229,237 |
| 2014 | 771 | 7,817 | 74 | 1.93 | $895,153 | $342,015 |
| 2013 | 566 | 7,896 | 73 | 1.88 | $776,171 | $291,023 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 123 | $63,676 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $15,754 | $105 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 90 | $13,437 | $117 |
| Return visit (30+ min) | 21 | $8,024 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $7,543 | $151 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $3,061 | $55 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 83 | $36,553 | $64 |
| Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | 13 | $32,521 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $23,288 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $12,490 | $176 |
| Return visit (30+ min) | 13 | $6,535 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $5,289 | $120 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $23,709 | $94 |
| Return visit (30+ min) | 18 | $19,498 | $85 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $10,517 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $10,437 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $4,594 | $66 |
| New patient visit (45+ min) | 11 | $1,304 | $119 |
2020: 6 services
| Return visit (30+ min) | 37 | $17,098 | $66 |
| Removal of skin and tissue, 20.0 sq cm or less | 39 | $11,496 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $7,683 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,599 | $184 |
| New patient visit (45+ min) | 24 | $2,550 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,447 | $66 |
2019: 8 services
| Removal of skin and tissue, 20.0 sq cm or less | 49 | $13,567 | $51 |
| Short return visit (20+ min) | 37 | $9,511 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $8,468 | $93 |
| Return visit (30+ min) | 33 | $4,924 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,513 | $181 |
| New patient visit (45+ min) | 34 | $3,468 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $3,451 | $65 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 14 | $1,590 | $21 |
2018: 15 services
| Removal of skin and tissue, 20.0 sq cm or less | 79 | $24,494 | $52 |
| Short return visit (20+ min) | 67 | $22,886 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $13,035 | $92 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 21 | $10,178 | $76 |
| New patient visit (45+ min) | 78 | $8,235 | $106 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 25 | $6,640 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $6,455 | $65 |
| Return visit (30+ min) | 45 | $6,375 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $5,472 | $177 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 15 | $4,809 | $21 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 13 | $4,348 | $68 |
| New patient visit (45+ min) | 24 | $3,200 | $133 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 15 | $2,277 | $152 |
| Return visit (30+ min) | 18 | $1,655 | $75 |
| Removal of tissue from wound, 20.0 sq cm or less | 12 | $317 | $21 |
2017: 15 services
| Short return visit (20+ min) | 56 | $15,765 | $38 |
| Removal of skin and tissue, 20.0 sq cm or less | 56 | $15,111 | $45 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 21 | $8,060 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $7,318 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,253 | $165 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 31 | $5,454 | $60 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 17 | $4,731 | $19 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $4,602 | $89 |
| New patient visit (45+ min) | 34 | $3,366 | $99 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 24 | $3,344 | $139 |
| New patient visit (45+ min) | 23 | $3,319 | $144 |
| Return visit (30+ min) | 33 | $3,117 | $59 |
| Return visit (30+ min) | 13 | $1,611 | $101 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 12 | $1,298 | $108 |
| Nursing facility discharge management, more than 30 minutes | 14 | $1,186 | $85 |
2016: 18 services
| Short return visit (20+ min) | 90 | $21,836 | $40 |
| Removal of skin and tissue, 20.0 sq cm or less | 84 | $17,762 | $49 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 65 | $9,340 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $8,739 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $8,134 | $163 |
| New patient visit (45+ min) | 81 | $7,990 | $99 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 47 | $7,062 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $7,057 | $81 |
| Return visit (30+ min) | 52 | $6,756 | $61 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 33 | $6,049 | $78 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 16 | $4,035 | $66 |
| Nursing facility discharge management, more than 30 minutes | 41 | $3,733 | $89 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 25 | $3,461 | $138 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 21 | $2,752 | $115 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 23 | $2,545 | $19 |
| Nursing facility discharge day management, 30 minutes or less | 20 | $1,424 | $62 |
| Short return visit (20+ min) | 11 | $697 | $54 |
| Application of chemical to stop tissue regrowth in wound | 11 | $477 | $30 |
2015: 20 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 275 | $68,503 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 273 | $50,265 | $158 |
| Short return visit (20+ min) | 193 | $24,991 | $42 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 84 | $18,741 | $47 |
| Hospital discharge day management, more than 30 minutes | 103 | $9,670 | $83 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 13 | $8,382 | $45 |
| Return visit (30+ min) | 87 | $7,977 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $6,805 | $82 |
| Initial hospital observation care per day, typically 70 minutes | 27 | $3,931 | $146 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 48 | $3,687 | $67 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 13 | $3,219 | $12 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 19 | $2,749 | $137 |
| Return visit (30+ min) | 11 | $1,910 | $62 |
| Short return visit (20+ min) | 16 | $1,829 | $38 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 19 | $1,757 | $92 |
| Hospital observation care on day of discharge | 22 | $1,243 | $56 |
| Follow-up observation care per day, typically 25 minutes | 11 | $738 | $57 |
| Hemoglobin a1c level, by device for home use | 25 | $557 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 62 | $499 | $6 |
| Insertion of needle into vein for collection of blood sample | 64 | $353 | $3 |
2014: 24 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 355 | $104,347 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 372 | $71,135 | $156 |
| Short return visit (20+ min) | 242 | $39,269 | $45 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 115 | $21,334 | $49 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 20 | $18,871 | $48 |
| Return visit (30+ min) | 118 | $13,160 | $73 |
| Hospital discharge day management, more than 30 minutes | 113 | $10,353 | $82 |
| Initial hospital observation care per day, typically 70 minutes | 69 | $10,187 | $141 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 18 | $6,992 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $6,014 | $77 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 47 | $3,615 | $68 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 30 | $3,060 | $99 |
| Short return visit (20+ min) | 14 | $2,280 | $38 |
| Hospital observation care on day of discharge | 39 | $2,151 | $54 |
| Administration of influenza virus vaccine | 86 | $1,957 | $22 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,616 | $108 |
| Follow-up observation care per day, typically 25 minutes | 24 | $1,589 | $55 |
| Return visit (30+ min) | 11 | $1,536 | $53 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 80 | $909 | $11 |
| Hemoglobin a1c level, by device for home use | 26 | $623 | $13 |
| Insertion of needle into vein for collection of blood sample | 68 | $559 | $3 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 21 | $227 | $7 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 11 | $100 | None |
| Infusion, normal saline solution, 250 cc | 11 | $39 | None |
2013: 26 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 211 | $73,603 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 217 | $45,150 | $154 |
| Short return visit (20+ min) | 235 | $39,734 | $47 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 26 | $27,340 | $55 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 116 | $24,831 | $49 |
| Return visit (30+ min) | 146 | $15,227 | $68 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 25 | $13,475 | $16 |
| Hospital discharge day management, more than 30 minutes | 53 | $6,480 | $81 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 51 | $4,013 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $3,294 | $78 |
| Short return visit (20+ min) | 24 | $2,898 | $38 |
| Initial hospital observation care per day, typically 70 minutes | 17 | $2,671 | $141 |
| Return visit (30+ min) | 26 | $2,449 | $58 |
| Removal of tissue from wound, 20.0 sq cm or less | 19 | $2,163 | $50 |
| Administration of influenza virus vaccine | 71 | $1,708 | $24 |
| Injection, vancomycin hcl, 500 mg | 13 | $1,386 | None |
| Application of chemical to stop tissue regrowth in wound | 13 | $1,095 | $52 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 12 | $950 | $79 |
| Hemoglobin a1c level, by device for home use | 28 | $801 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 32 | $776 | $6 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 65 | $735 | $11 |
| Insertion of needle into vein for collection of blood sample | 61 | $427 | $3 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 16 | $137 | None |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 13 | $84 | $6 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 13 | $76 | $6 |
| Infusion, normal saline solution, 250 cc | 13 | $36 | None |
Medicaid work
$61,241 in 2024
Medicaid paid $61,241 for 1,033 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 170 | $61,241 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 431 | $0 |
| Telehealth originating site facility fee | 432 | $0 |
| 2024 | 1,033 | 3 | 29 | $61,241 |
| 2023 | 2,326 | 7 | 75 | $140,174 |
| 2022 | 87 | 4 | 19 | $8,066 |
| 2018 | 115 | 2 | 12 | $1,890 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 366 | $125,699 |
| Service | 129 | $10,583 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 262 | $3,892 |
| Short return visit (20+ min) | 205 | $0 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 632 | $0 |
| Telehealth originating site facility fee | 637 | $0 |
| Service | 95 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 19 | $6,754 |
| Service | 16 | $1,313 |
| Short return visit (20+ min) | 33 | $0 |
| Service | 19 | $0 |
2018
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 89 | $1,257 |
| Short return visit (20+ min) | 26 | $633 |
Drugs they prescribed that Part D paid
$18,020
Pharmacies billed $18,020 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 311) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
285 generic and 26 brand-name prescriptions · $18,020 in drug cost · 30 antibiotic prescriptions to 13 people · 32 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 12 | $7,680 | $640 |
| Raloxifene | 12 | $510 | $43 |
| Escitalopram | 25 | $456 | $18 |
| Quetiapine | 20 | $383 | $19 |
| Olanzapine | 12 | $326 | $27 |
See all 14 drugs
| Eliquis | 12 | $7,680 | $640 |
| Raloxifene | 12 | $510 | $43 |
| Escitalopram | 25 | $456 | $18 |
| Quetiapine | 20 | $383 | $19 |
| Olanzapine | 12 | $326 | $27 |
| Losartan | 13 | $291 | $22 |
| Nystatin | 11 | $284 | $26 |
| Sertraline | 14 | $275 | $20 |
| Metformin | 13 | $256 | $20 |
| Diltiazem | 12 | $250 | $21 |
| Donepezil | 23 | $240 | $10 |
| Rosuvastatin | 11 | $236 | $21 |
| Amlodipine Besylate | 13 | $66 | $5 |
| Hydrochlorothiazide | 12 | $55 | $5 |
Year by year
| 2024 | 311 | 41 | 0% (0) | 8% | $18,020 |
| 2023 | 480 | 80 | None | None | $29,658 |
| 2022 | 498 | 60 | 2% (12) | 6% | $12,727 |
| 2021 | 409 | 43 | 3% (14) | 13% | $24,024 |
| 2020 | 651 | 44 | 4% (24) | 14% | $40,316 |
| 2019 | 850 | 48 | 4% (36) | 22% | $67,007 |
| 2018 | 1,414 | 109 | 2% (28) | 23% | $101,147 |
| 2017 | 1,526 | 110 | 2% (25) | None | $129,111 |
| 2016 | 1,807 | 189 | 2% (39) | 21% | $118,650 |
| 2015 | 9,583 | 410 | 3% (306) | 22% | $766,443 |
| 2014 | 8,002 | 391 | 4% (294) | 21% | $588,196 |
| 2013 | 6,898 | 322 | 3% (227) | 21% | $485,118 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Eliquis | 12 | $6,948 | $579 |
| Breo Ellipta | 13 | $2,130 | $164 |
| Raloxifene | 12 | $1,949 | $162 |
| Diclofenac | 27 | $1,816 | $67 |
| Dronabinol | 12 | $1,299 | $108 |
| Diltiazem | 13 | $870 | $67 |
| Losartan | 28 | $720 | $26 |
| Escitalopram | 33 | $636 | $19 |
| Donepezil | 28 | $456 | $16 |
| Olanzapine | 17 | $408 | $24 |
| Sertraline | 26 | $366 | $14 |
| Quetiapine | 22 | $334 | $15 |
| Gabapentin | 13 | $319 | $25 |
| Rosuvastatin | 14 | $304 | $22 |
| Atorvastatin | 18 | $300 | $17 |
| Metformin | 15 | $249 | $17 |
| Prednisone | 18 | $198 | $11 |
| Levothyroxine | 12 | $109 | $9 |
| Hydrochlorothiazide | 15 | $70 | $5 |
2022: 17 drugs
| Atorvastatin | 45 | $609 | $14 |
| Olanzapine | 16 | $515 | $32 |
| Donepezil | 30 | $459 | $15 |
| Escitalopram | 23 | $393 | $17 |
| Methadone | 12 | $311 | $26 |
| Losartan | 19 | $305 | $16 |
| Quetiapine | 31 | $302 | $10 |
| Metformin | 28 | $286 | $10 |
| Gabapentin | 11 | $225 | $20 |
| Sertraline | 16 | $219 | $14 |
| Hydrochlorothiazide | 25 | $208 | $8 |
| Levothyroxine | 18 | $198 | $11 |
| Lisinopril | 12 | $162 | $14 |
| Amlodipine Besylate | 20 | $137 | $7 |
| Triamcinolone Acetonide | 12 | $125 | $10 |
| Carvedilol | 13 | $43 | $3 |
| Furosemide | 13 | $36 | $3 |
2021: 20 drugs
| Eliquis | 14 | $7,127 | $509 |
| Breo Ellipta | 13 | $2,054 | $158 |
| Memantine | 14 | $1,836 | $131 |
| Flecainide Acetate | 12 | $1,537 | $128 |
| Olanzapine | 19 | $1,495 | $79 |
| Levetiracetam | 12 | $412 | $34 |
| Atorvastatin | 24 | $360 | $15 |
| Methadone | 13 | $337 | $26 |
| Metoprolol | 12 | $314 | $26 |
| Donepezil | 21 | $307 | $15 |
| Gabapentin | 13 | $232 | $18 |
| Amlodipine Besylate | 17 | $197 | $12 |
| Gemfibrozil | 12 | $187 | $16 |
| Sertraline | 12 | $183 | $15 |
| Levothyroxine | 18 | $182 | $10 |
| Trazodone | 17 | $181 | $11 |
| Metformin | 15 | $148 | $10 |
| Hydrochlorothiazide | 13 | $125 | $10 |
| Lisinopril | 13 | $117 | $9 |
| Prednisone | 16 | $93 | $6 |
2020: 28 drugs
| Eliquis | 21 | $6,186 | $295 |
| Ondansetron | 12 | $5,449 | $454 |
| Breo Ellipta | 17 | $2,619 | $154 |
| Betamethasone Dipropionate | 12 | $1,673 | $139 |
| Memantine | 19 | $1,439 | $76 |
| Divalproex | 12 | $1,397 | $116 |
| Olanzapine | 11 | $770 | $70 |
| Atorvastatin | 31 | $583 | $19 |
| Benazepril | 21 | $525 | $25 |
| Amlodipine Besylate | 18 | $402 | $22 |
| Carbidopa-Levodopa | 16 | $386 | $24 |
| Levetiracetam | 14 | $341 | $24 |
| Donepezil | 25 | $281 | $11 |
| Nystop | 12 | $272 | $23 |
| Methadone | 11 | $258 | $23 |
| Gemfibrozil | 12 | $239 | $20 |
| Quetiapine | 18 | $224 | $12 |
| Levothyroxine | 18 | $213 | $12 |
| Atenolol | 13 | $199 | $15 |
| Tamsulosin | 12 | $191 | $16 |
| Lisinopril | 22 | $159 | $7 |
| Oxycodone-Acetaminophen | 13 | $153 | $12 |
| Citalopram Hbr | 17 | $144 | $8 |
| Trazodone | 19 | $141 | $7 |
| Metformin | 14 | $118 | $8 |
| Prednisone | 15 | $106 | $7 |
| Metoprolol | 21 | $84 | $4 |
| Furosemide | 12 | $63 | $5 |
2019: 39 drugs
| Ondansetron | 20 | $7,659 | $383 |
| Santyl | 15 | $7,525 | $502 |
| Lantus | 25 | $7,510 | $300 |
| Neupro | 12 | $6,915 | $576 |
| Eliquis | 23 | $4,957 | $216 |
| Rivastigmine | 12 | $4,397 | $366 |
| Novolog | 13 | $4,108 | $316 |
| Betamethasone Dipropionate | 22 | $2,442 | $111 |
| Breo Ellipta | 14 | $2,328 | $166 |
| Lidocaine-Prilocaine | 38 | $1,528 | $40 |
| Celecoxib | 12 | $1,305 | $109 |
| Gabapentin | 30 | $1,109 | $37 |
| Memantine | 12 | $817 | $68 |
| Atorvastatin | 42 | $765 | $18 |
| Benazepril | 24 | $646 | $27 |
| Carbidopa-Levodopa | 23 | $562 | $24 |
| Olanzapine | 12 | $491 | $41 |
| Dorzolamide | 11 | $464 | $42 |
| Diltiazem 24hr Er (Cd) | 11 | $404 | $37 |
| Oxycodone | 19 | $395 | $21 |
| Amlodipine Besylate | 14 | $351 | $25 |
| Furosemide | 46 | $342 | $7 |
| Citalopram Hbr | 33 | $298 | $9 |
| Donepezil | 22 | $287 | $13 |
| Levothyroxine | 22 | $276 | $13 |
| Hydroxyzine | 14 | $261 | $19 |
| Metoprolol | 12 | $242 | $20 |
| Ipratropium-Albuterol | 11 | $230 | $21 |
| Oxycodone-Acetaminophen | 15 | $209 | $14 |
| Tamsulosin | 12 | $197 | $16 |
| Atenolol | 12 | $184 | $15 |
| Sertraline | 12 | $149 | $12 |
| Trazodone | 13 | $147 | $11 |
| Tizanidine | 13 | $138 | $11 |
| Quetiapine | 14 | $135 | $10 |
| Prednisone | 18 | $129 | $7 |
| Famotidine | 11 | $109 | $10 |
| Meloxicam | 11 | $74 | $7 |
| Hydrochlorothiazide | 11 | $71 | $6 |
2018: 41 drugs
| Lantus | 33 | $9,357 | $284 |
| Santyl | 23 | $8,871 | $386 |
| Ondansetron | 34 | $7,405 | $218 |
| Neupro | 17 | $5,979 | $352 |
| Eliquis | 24 | $5,148 | $215 |
| Vimpat | 11 | $4,768 | $433 |
| Rivastigmine | 11 | $4,011 | $365 |
| Novolog | 12 | $3,756 | $313 |
| Xarelto | 17 | $3,675 | $216 |
| Novolog Flexpen | 26 | $3,311 | $127 |
| Lidocaine-Prilocaine | 44 | $1,907 | $43 |
| Nystop | 44 | $1,610 | $37 |
| Atorvastatin | 68 | $1,158 | $17 |
| Gabapentin | 39 | $1,094 | $28 |
| Carbidopa-Levodopa | 28 | $706 | $25 |
| Doxycycline Hyclate | 24 | $705 | $29 |
| Benazepril | 29 | $649 | $22 |
| Oxybutynin Chloride Er | 14 | $566 | $40 |
| Amlodipine Besylate | 33 | $536 | $16 |
| Metoprolol | 29 | $530 | $18 |
| Olanzapine | 11 | $508 | $46 |
| Levothyroxine | 39 | $448 | $11 |
| Tamsulosin | 23 | $442 | $19 |
| Latanoprost | 24 | $421 | $18 |
| Diltiazem 24hr Er (Cd) | 12 | $401 | $33 |
| Furosemide | 71 | $388 | $5 |
| Sertraline | 36 | $334 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $306 | $26 |
| Donepezil | 17 | $260 | $15 |
| Citalopram Hbr | 26 | $257 | $10 |
| Prednisone | 28 | $213 | $8 |
| Brimonidine | 11 | $194 | $18 |
| Pantoprazole | 20 | $171 | $9 |
| Atenolol | 12 | $165 | $14 |
| Trazodone | 14 | $163 | $12 |
| Lisinopril | 17 | $135 | $8 |
| Carvedilol | 13 | $127 | $10 |
| Hydrochlorothiazide | 24 | $125 | $5 |
| Azithromycin | 13 | $115 | $9 |
| Losartan | 13 | $100 | $8 |
| Meloxicam | 12 | $77 | $6 |
2017: 50 drugs
| Santyl | 23 | $12,379 | $538 |
| Lantus | 32 | $8,703 | $272 |
| Neupro | 24 | $8,121 | $338 |
| Eliquis | 37 | $7,251 | $196 |
| Ondansetron | 15 | $7,218 | $481 |
| Namenda Xr | 30 | $5,953 | $198 |
| Lyrica | 21 | $4,625 | $220 |
| Novolog | 15 | $4,475 | $298 |
| Rivastigmine | 11 | $4,049 | $368 |
| Breo Ellipta | 11 | $3,861 | $351 |
| Nuedexta | 14 | $2,675 | $191 |
| Carbidopa-Levodopa | 32 | $1,743 | $54 |
| Atorvastatin | 67 | $1,388 | $21 |
| Memantine | 25 | $1,368 | $55 |
| Oxybutynin Chloride Er | 24 | $971 | $40 |
| Amlodipine Besylate | 54 | $782 | $14 |
| Gabapentin | 37 | $750 | $20 |
| Tamsulosin | 35 | $725 | $21 |
| Olanzapine | 19 | $653 | $34 |
| Sertraline | 66 | $625 | $9 |
| Lactulose | 25 | $619 | $25 |
| Metoprolol | 43 | $561 | $13 |
| Alprazolam | 46 | $558 | $12 |
| Nystop | 18 | $552 | $31 |
| Furosemide | 71 | $521 | $7 |
| Benazepril | 24 | $486 | $20 |
| Oxybutynin Chloride | 12 | $484 | $40 |
| Levothyroxine | 32 | $484 | $15 |
| Doxycycline Hyclate | 13 | $474 | $36 |
| Diltiazem 24hr Er | 15 | $398 | $27 |
| Trazodone | 28 | $343 | $12 |
| Lisinopril | 27 | $321 | $12 |
| Donepezil | 20 | $300 | $15 |
| Pantoprazole | 17 | $244 | $14 |
| Citalopram Hbr | 28 | $244 | $9 |
| Latanoprost | 14 | $214 | $15 |
| Losartan | 28 | $210 | $8 |
| Prednisone | 36 | $206 | $6 |
| Amoxicillin-Clavulanate Potass | 13 | $180 | $14 |
| Amiodarone | 13 | $177 | $14 |
| Atenolol | 12 | $176 | $15 |
| Clopidogrel | 11 | $170 | $15 |
| Metoclopramide | 11 | $139 | $13 |
| Metoprolol | 11 | $120 | $11 |
| Ciprofloxacin | 11 | $109 | $10 |
| Carvedilol | 14 | $95 | $7 |
| Azithromycin | 12 | $78 | $6 |
| Warfarin | 13 | $76 | $6 |
| Hydrochlorothiazide | 16 | $72 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $58 | $5 |
2016: 47 drugs
| Santyl | 37 | $19,916 | $538 |
| Namenda Xr | 47 | $8,282 | $176 |
| Lantus | 25 | $7,562 | $302 |
| Nuedexta | 20 | $3,540 | $177 |
| Memantine | 41 | $1,885 | $46 |
| Raloxifene | 13 | $1,496 | $115 |
| Doxycycline Hyclate | 26 | $1,139 | $44 |
| Fenofibrate | 17 | $917 | $54 |
| Quetiapine | 41 | $910 | $22 |
| Atorvastatin | 52 | $899 | $17 |
| Carbamazepine Er | 13 | $768 | $59 |
| Tamsulosin | 41 | $758 | $18 |
| Venlafaxine | 12 | $754 | $63 |
| Sertraline | 54 | $689 | $13 |
| Amlodipine Besylate | 64 | $654 | $10 |
| Levothyroxine | 43 | $537 | $12 |
| Potassium Chloride | 15 | $527 | $35 |
| Lisinopril | 30 | $439 | $15 |
| Alprazolam | 27 | $412 | $15 |
| Olanzapine | 12 | $398 | $33 |
| Carbidopa-Levodopa | 13 | $395 | $30 |
| Gabapentin | 38 | $393 | $10 |
| Donepezil | 25 | $357 | $14 |
| Warfarin | 58 | $340 | $6 |
| Escitalopram | 14 | $333 | $24 |
| Furosemide | 53 | $333 | $6 |
| Trazodone | 32 | $324 | $10 |
| Levofloxacin | 13 | $303 | $23 |
| Clonidine | 23 | $292 | $13 |
| Acetaminophen-Codeine | 21 | $265 | $13 |
| Metoprolol | 29 | $262 | $9 |
| Irbesartan | 20 | $259 | $13 |
| Amiodarone | 17 | $251 | $15 |
| Clopidogrel | 11 | $245 | $22 |
| Nystop | 11 | $224 | $20 |
| Finasteride | 11 | $185 | $17 |
| Metformin | 23 | $176 | $8 |
| Omeprazole | 15 | $173 | $12 |
| Sulfamethoxazole-Trimethoprim | 24 | $172 | $7 |
| Simvastatin | 13 | $163 | $13 |
| Citalopram Hbr | 23 | $155 | $7 |
| Benazepril | 11 | $146 | $13 |
| Ibuprofen | 17 | $134 | $8 |
| Prednisone | 22 | $115 | $5 |
| Cilostazol | 13 | $90 | $7 |
| Losartan | 13 | $87 | $7 |
| Glipizide | 13 | $84 | $6 |
2015: 189 drugs
| Atripla | 14 | $31,603 | $2,257 |
| Namenda Xr | 170 | $29,832 | $175 |
| Levemir | 52 | $24,007 | $462 |
| Lantus | 65 | $23,279 | $358 |
| Isentress | 11 | $20,225 | $1,839 |
| Lantus Solostar | 37 | $19,052 | $515 |
| Nuedexta | 54 | $18,710 | $346 |
| Latuda | 42 | $18,430 | $439 |
| Abilify | 40 | $18,023 | $451 |
| Januvia | 44 | $15,706 | $357 |
| Reyataz | 12 | $15,052 | $1,254 |
| Humalog | 37 | $14,714 | $398 |
| Kaletra | 11 | $14,289 | $1,299 |
| Risperdal Consta | 23 | $14,062 | $611 |
| Seroquel Xr | 16 | $11,231 | $702 |
| Xarelto | 33 | $10,139 | $307 |
| Crestor | 40 | $9,263 | $232 |
| Novolog | 38 | $8,930 | $235 |
| Advair Diskus | 22 | $8,494 | $386 |
| Santyl | 20 | $7,373 | $369 |
| Uloric | 17 | $7,161 | $421 |
| Spiriva | 21 | $6,835 | $325 |
| Creon | 11 | $6,702 | $609 |
| Nuvigil | 12 | $6,535 | $545 |
| Hydrocodone-Acetaminophen | 199 | $6,126 | $31 |
| Symbicort | 19 | $5,668 | $298 |
| Nystatin-Triamcinolone | 23 | $5,474 | $238 |
| Namenda | 27 | $5,156 | $191 |
| Donepezil | 154 | $5,014 | $33 |
| Aripiprazole | 13 | $4,981 | $383 |
| Levothyroxine | 292 | $4,936 | $17 |
| Divalproex | 68 | $4,897 | $72 |
| Olanzapine | 55 | $4,858 | $88 |
| Exelon | 11 | $4,843 | $440 |
| Atorvastatin | 212 | $4,408 | $21 |
| Potassium Chloride | 180 | $4,127 | $23 |
| Proair Hfa | 67 | $3,915 | $58 |
| Zetia | 14 | $3,570 | $255 |
| Fluoxetine | 32 | $3,236 | $101 |
| Norvir | 12 | $3,070 | $256 |
| Raloxifene | 28 | $2,898 | $103 |
| Transderm-Scop | 17 | $2,833 | $167 |
| Duloxetine | 48 | $2,792 | $58 |
| Doxycycline Hyclate | 59 | $2,693 | $46 |
| Amlodipine Besylate | 279 | $2,656 | $10 |
| Clotrimazole-Betamethasone | 36 | $2,580 | $72 |
| Pradaxa | 21 | $2,580 | $123 |
| Metoprolol | 96 | $2,547 | $27 |
| Metoprolol | 271 | $2,369 | $9 |
| Tamsulosin | 92 | $2,281 | $25 |
| Oxycodone-Acetaminophen | 14 | $2,201 | $157 |
| Quetiapine | 53 | $2,178 | $41 |
| Metaxalone | 14 | $2,153 | $154 |
| Gabapentin | 155 | $2,051 | $13 |
| Celecoxib | 13 | $2,026 | $156 |
| Carbamazepine Er | 17 | $2,013 | $118 |
| Daliresp | 15 | $2,009 | $134 |
| Lisinopril | 215 | $2,002 | $9 |
| Ventolin Hfa | 33 | $1,755 | $53 |
| Novolin R | 13 | $1,739 | $134 |
| Fenofibrate | 31 | $1,683 | $54 |
| Oxybutynin Chloride Er | 31 | $1,681 | $54 |
| Novolog Flexpen | 18 | $1,672 | $93 |
| Furosemide | 286 | $1,664 | $6 |
| Haloperidol | 38 | $1,656 | $44 |
| Metformin | 207 | $1,617 | $8 |
| Sertraline | 138 | $1,606 | $12 |
| Divalproex Sodium Er | 25 | $1,571 | $63 |
| Venlafaxine | 34 | $1,566 | $46 |
| Omeprazole | 94 | $1,556 | $17 |
| Losartan | 93 | $1,529 | $16 |
| Valsartan-Hydrochlorothiazide | 31 | $1,466 | $47 |
| Mirtazapine | 57 | $1,450 | $25 |
| Novolin 70-30 | 11 | $1,431 | $130 |
| Fluticasone Propionate | 64 | $1,393 | $22 |
| Pravastatin | 30 | $1,356 | $45 |
| Simvastatin | 172 | $1,323 | $8 |
| Risperidone | 82 | $1,250 | $15 |
| Warfarin | 118 | $1,250 | $11 |
| Levetiracetam | 59 | $1,218 | $21 |
| Clopidogrel | 94 | $1,125 | $12 |
| Bystolic | 12 | $1,124 | $94 |
| Bupropion Hcl Sr | 49 | $1,119 | $23 |
| Baclofen | 41 | $1,106 | $27 |
| Alprazolam | 131 | $1,099 | $8 |
| Trazodone | 86 | $1,065 | $12 |
| Benztropine Mesylate | 69 | $1,064 | $15 |
| Montelukast | 27 | $1,047 | $39 |
| Ranitidine | 53 | $976 | $18 |
| Niacin Er | 22 | $970 | $44 |
| Clonidine | 90 | $962 | $11 |
| Colestipol | 12 | $948 | $79 |
| Fentanyl | 16 | $917 | $57 |
| Isosorbide Mononitrate Er | 80 | $911 | $11 |
| Thiothixene | 13 | $852 | $66 |
| Glimepiride | 48 | $838 | $17 |
| Valsartan | 30 | $833 | $28 |
| Paroxetine | 42 | $793 | $19 |
| Azelastine | 13 | $792 | $61 |
| Lisinopril-Hydrochlorothiazide | 57 | $785 | $14 |
| Ropinirole | 42 | $782 | $19 |
| Verapamil Er | 42 | $764 | $18 |
| Hydrochlorothiazide | 89 | $754 | $8 |
| Citalopram Hbr | 72 | $733 | $10 |
| Dorzolamide | 22 | $733 | $33 |
| Betamethasone Dipropionate | 18 | $723 | $40 |
| Isosorbide Dinitrate | 26 | $714 | $27 |
| Cilostazol | 56 | $708 | $13 |
| Torsemide | 53 | $703 | $13 |
| Nystatin | 26 | $700 | $27 |
| Metolazone | 15 | $699 | $47 |
| Buspirone | 16 | $682 | $43 |
| Lorazepam | 75 | $637 | $8 |
| Amitriptyline | 19 | $591 | $31 |
| Fenofibrate | 13 | $585 | $45 |
| Zolpidem | 42 | $585 | $14 |
| Amiodarone | 12 | $585 | $49 |
| Bumetanide | 19 | $565 | $30 |
| Hydralazine | 24 | $559 | $23 |
| Ceftriaxone | 15 | $559 | $37 |
| Atenolol | 90 | $544 | $6 |
| Naltrexone | 12 | $533 | $44 |
| Glipizide | 80 | $527 | $7 |
| Escitalopram | 65 | $514 | $8 |
| Alendronate | 60 | $489 | $8 |
| Hydroxyzine | 23 | $482 | $21 |
| Probenecid | 14 | $466 | $33 |
| Pantoprazole | 38 | $466 | $12 |
| Klor-Con M20 | 26 | $460 | $18 |
| Ibuprofen | 39 | $454 | $12 |
| Levofloxacin | 56 | $443 | $8 |
| Carvedilol | 52 | $440 | $8 |
| Bd Ultra-Fine Pen Needle | 11 | $434 | $39 |
| Clonazepam | 55 | $433 | $8 |
| Spironolactone | 40 | $399 | $10 |
| Ipratropium-Albuterol | 22 | $388 | $18 |
| Novofine Autocover | 13 | $383 | $29 |
| Diltiazem | 12 | $382 | $32 |
| Polyethylene Glycol 3350 | 18 | $380 | $21 |
| Carbidopa-Levodopa | 12 | $380 | $32 |
| Ipratropium | 23 | $367 | $16 |
| Amlodipine Besylate-Benazepril | 18 | $358 | $20 |
| Ciprofloxacin | 28 | $358 | $13 |
| Meloxicam | 66 | $356 | $5 |
| Allopurinol | 38 | $353 | $9 |
| Meclizine | 20 | $342 | $17 |
| Fluphenazine | 14 | $340 | $24 |
| Irbesartan | 30 | $336 | $11 |
| Losartan-Hydrochlorothiazide | 31 | $335 | $11 |
| Klor-Con M10 | 17 | $330 | $19 |
| Silver Sulfadiazine | 20 | $327 | $16 |
| Amoxicillin-Clavulanate Potass | 30 | $325 | $11 |
| Topiramate | 16 | $318 | $20 |
| Tegretol Xr | 11 | $316 | $29 |
| Lithium Carbonate | 37 | $314 | $8 |
| Venlafaxine Hcl Er | 18 | $301 | $17 |
| Prednisone | 45 | $299 | $7 |
| Felodipine Er | 12 | $296 | $25 |
| Famotidine | 41 | $290 | $7 |
| Latanoprost | 12 | $275 | $23 |
| Tramadol | 39 | $266 | $7 |
| Ondansetron | 14 | $263 | $19 |
| Dipyridamole | 17 | $259 | $15 |
| Sulfamethoxazole-Trimethoprim | 37 | $255 | $7 |
| Albuterol Sulfate | 13 | $253 | $19 |
| Cyclobenzaprine | 21 | $247 | $12 |
| Klor-Con 8 | 11 | $244 | $22 |
| Finasteride | 22 | $234 | $11 |
| Tramadol Hcl-Acetaminophen | 13 | $230 | $18 |
| Tizanidine | 14 | $225 | $16 |
| Primidone | 12 | $215 | $18 |
| Sodium Chloride | 18 | $214 | $12 |
| Glipizide Er | 13 | $213 | $16 |
| Lovastatin | 33 | $212 | $6 |
| Lidocaine | 13 | $193 | $15 |
| Metronidazole | 12 | $179 | $15 |
| Brimonidine | 13 | $170 | $13 |
| Trihexyphenidyl | 15 | $167 | $11 |
| Nitrostat | 11 | $153 | $14 |
| Cephalexin | 19 | $143 | $8 |
| Cefadroxil | 16 | $136 | $9 |
| Metformin Hcl Er | 15 | $134 | $9 |
| Diltiazem Er | 12 | $130 | $11 |
| Lamotrigine | 12 | $124 | $10 |
| Dexamethasone | 15 | $116 | $8 |
| Metoclopramide | 15 | $105 | $7 |
| Bisoprolol-Hydrochlorothiazide | 14 | $95 | $7 |
| Diazepam | 30 | $74 | $2 |
| Temazepam | 14 | $72 | $5 |
2014: 149 drugs
| Atripla | 24 | $49,888 | $2,079 |
| Levemir Flexpen | 19 | $25,758 | $1,356 |
| Isentress | 13 | $23,595 | $1,815 |
| Truvada | 13 | $19,818 | $1,524 |
| Namenda Xr | 108 | $19,523 | $181 |
| Levemir | 46 | $19,358 | $421 |
| Namenda | 70 | $16,534 | $236 |
| Kaletra | 11 | $15,349 | $1,395 |
| Januvia | 45 | $12,150 | $270 |
| Nuedexta | 34 | $11,217 | $330 |
| Abilify | 26 | $10,601 | $408 |
| Humalog | 32 | $9,808 | $307 |
| Xarelto | 31 | $9,632 | $311 |
| Lantus | 24 | $7,820 | $326 |
| Advair Diskus | 19 | $6,754 | $355 |
| Uloric | 13 | $6,748 | $519 |
| Crestor | 35 | $6,741 | $193 |
| Celebrex | 20 | $6,626 | $331 |
| Nuvigil | 12 | $5,966 | $497 |
| Janumet | 13 | $5,398 | $415 |
| Lidocaine | 35 | $5,346 | $153 |
| Novolog | 26 | $5,161 | $199 |
| Lantus Solostar | 21 | $5,157 | $246 |
| Hydrocodone-Acetaminophen | 188 | $4,729 | $25 |
| Duloxetine | 30 | $4,586 | $153 |
| Creon | 11 | $4,474 | $407 |
| Diovan | 32 | $4,261 | $133 |
| Santyl | 21 | $4,216 | $201 |
| Nystatin-Triamcinolone | 20 | $4,040 | $202 |
| Doxycycline Hyclate | 81 | $3,884 | $48 |
| Pradaxa | 23 | $3,872 | $168 |
| Proair Hfa | 60 | $3,673 | $61 |
| Levothyroxine | 238 | $3,550 | $15 |
| Potassium Chloride | 186 | $3,405 | $18 |
| Metoprolol | 83 | $3,384 | $41 |
| Clotrimazole-Betamethasone | 40 | $3,204 | $80 |
| Valsartan-Hydrochlorothiazide | 53 | $2,870 | $54 |
| Atorvastatin | 171 | $2,684 | $16 |
| Bystolic | 22 | $2,683 | $122 |
| Vytorin | 13 | $2,523 | $194 |
| Fluoxetine | 27 | $2,396 | $89 |
| Amlodipine Besylate | 249 | $1,934 | $8 |
| Valsartan | 11 | $1,827 | $166 |
| Lisinopril | 212 | $1,793 | $8 |
| Donepezil | 174 | $1,770 | $10 |
| Gabapentin | 111 | $1,699 | $15 |
| Omeprazole | 108 | $1,639 | $15 |
| Simvastatin | 173 | $1,589 | $9 |
| Tamsulosin | 70 | $1,564 | $22 |
| Furosemide | 291 | $1,500 | $5 |
| Oxybutynin Chloride Er | 33 | $1,496 | $45 |
| Divalproex | 16 | $1,465 | $92 |
| Metformin | 181 | $1,385 | $8 |
| Clopidogrel | 91 | $1,369 | $15 |
| Metoprolol | 205 | $1,357 | $7 |
| Alprazolam | 142 | $1,263 | $9 |
| Lansoprazole | 12 | $1,255 | $105 |
| Montelukast | 16 | $1,150 | $72 |
| Oxycodone | 12 | $1,119 | $93 |
| Betamethasone Dipropionate | 21 | $1,116 | $53 |
| Warfarin | 142 | $1,114 | $8 |
| Fenofibrate | 16 | $1,051 | $66 |
| Fenofibrate | 14 | $1,040 | $74 |
| Pioglitazone-Metformin | 11 | $1,014 | $92 |
| Metolazone | 45 | $1,013 | $23 |
| Hydrochlorothiazide | 106 | $1,002 | $9 |
| Isosorbide Mononitrate Er | 89 | $989 | $11 |
| Alendronate | 65 | $982 | $15 |
| Verapamil Er | 39 | $966 | $25 |
| Ventolin Hfa | 21 | $954 | $45 |
| Sertraline | 123 | $939 | $8 |
| Levetiracetam | 59 | $924 | $16 |
| Fentanyl | 17 | $906 | $53 |
| Risperidone | 76 | $854 | $11 |
| Cilostazol | 43 | $836 | $19 |
| Nyamyc | 20 | $819 | $41 |
| Lisinopril-Hydrochlorothiazide | 72 | $781 | $11 |
| Pravastatin | 21 | $770 | $37 |
| Escitalopram | 52 | $747 | $14 |
| Ropinirole | 38 | $746 | $20 |
| Glipizide | 101 | $709 | $7 |
| Quetiapine | 13 | $696 | $54 |
| Bd Ultra-Fine Pen Needle | 19 | $693 | $36 |
| Glimepiride | 45 | $671 | $15 |
| Dipyridamole | 38 | $670 | $18 |
| Losartan | 46 | $632 | $14 |
| Amantadine | 13 | $630 | $48 |
| Baclofen | 38 | $630 | $17 |
| Bumetanide | 26 | $629 | $24 |
| Silver Sulfadiazine | 29 | $614 | $21 |
| Lovastatin | 59 | $607 | $10 |
| Pantoprazole | 33 | $603 | $18 |
| Lorazepam | 65 | $583 | $9 |
| Sucralfate | 22 | $577 | $26 |
| Azelastine | 12 | $568 | $47 |
| Amlodipine Besylate-Benazepril | 29 | $552 | $19 |
| Atenolol | 88 | $526 | $6 |
| Zolpidem | 60 | $509 | $8 |
| Meloxicam | 74 | $499 | $7 |
| Hydralazine | 15 | $480 | $32 |
| Klor-Con 8 | 18 | $476 | $26 |
| Diltiazem 24hr Er | 16 | $474 | $30 |
| Fluticasone Propionate | 25 | $460 | $18 |
| Ranitidine | 45 | $452 | $10 |
| Famotidine | 51 | $446 | $9 |
| Isosorbide Dinitrate | 17 | $444 | $26 |
| Losartan-Hydrochlorothiazide | 34 | $428 | $13 |
| Sodium Chloride | 14 | $418 | $30 |
| Synthroid | 14 | $407 | $29 |
| Finasteride | 19 | $401 | $21 |
| Levofloxacin | 36 | $386 | $11 |
| Felodipine Er | 13 | $386 | $30 |
| Gentamicin Sulfate | 14 | $377 | $27 |
| Probenecid | 16 | $367 | $23 |
| Albuterol Sulfate | 26 | $346 | $13 |
| Clonidine | 41 | $318 | $8 |
| Benztropine Mesylate | 21 | $315 | $15 |
| Tramadol Hcl-Acetaminophen | 18 | $309 | $17 |
| Carisoprodol | 14 | $305 | $22 |
| Valproic Acid | 17 | $297 | $17 |
| Cyclobenzaprine | 33 | $297 | $9 |
| Amitriptyline | 14 | $282 | $20 |
| Nystatin | 11 | $281 | $26 |
| Sulfamethoxazole-Trimethoprim | 46 | $278 | $6 |
| Carvedilol | 36 | $276 | $8 |
| Clonazepam | 45 | $271 | $6 |
| Citalopram Hbr | 39 | $265 | $7 |
| Glyburide | 13 | $261 | $20 |
| Tramadol | 33 | $260 | $8 |
| Triamcinolone Acetonide | 18 | $258 | $14 |
| Terbinafine | 21 | $251 | $12 |
| Klor-Con M20 | 25 | $248 | $10 |
| Amox Tr-Potassium Clavulanate | 18 | $240 | $13 |
| Hydroxyzine | 14 | $230 | $16 |
| Cefadroxil | 19 | $215 | $11 |
| Torsemide | 13 | $209 | $16 |
| Prednisone | 30 | $203 | $7 |
| Spironolactone | 17 | $200 | $12 |
| Mirtazapine | 16 | $189 | $12 |
| Trazodone | 22 | $188 | $9 |
| Ciprofloxacin | 33 | $186 | $6 |
| Allopurinol | 24 | $182 | $8 |
| Azithromycin | 13 | $161 | $12 |
| Diazepam | 32 | $157 | $5 |
| Metronidazole | 12 | $153 | $13 |
| Chlordiazepoxide | 14 | $145 | $10 |
| Metformin Hcl Er | 15 | $125 | $8 |
| Bisoprolol-Hydrochlorothiazide | 16 | $109 | $7 |
| Temazepam | 14 | $70 | $5 |
2013: 143 drugs
| Atripla | 15 | $29,146 | $1,943 |
| Isentress | 14 | $23,511 | $1,679 |
| Namenda | 124 | $23,079 | $186 |
| Lamivudine-Zidovudine | 11 | $20,734 | $1,885 |
| Levemir Flexpen | 26 | $19,177 | $738 |
| Truvada | 15 | $19,152 | $1,277 |
| Sustiva | 11 | $13,527 | $1,230 |
| Januvia | 48 | $11,175 | $233 |
| Lidoderm | 38 | $10,033 | $264 |
| Levemir | 26 | $9,124 | $351 |
| Santyl | 37 | $8,178 | $221 |
| Abilify | 23 | $7,541 | $328 |
| Diovan | 60 | $7,347 | $122 |
| Advair Diskus | 22 | $6,980 | $317 |
| Humalog | 22 | $5,931 | $270 |
| Xarelto | 15 | $5,324 | $355 |
| Doxycycline Hyclate | 89 | $5,320 | $60 |
| Cymbalta | 22 | $5,185 | $236 |
| Donepezil | 125 | $5,109 | $41 |
| Spiriva | 14 | $5,053 | $361 |
| Atorvastatin | 99 | $4,536 | $46 |
| Lantus | 19 | $4,032 | $212 |
| Clopidogrel | 93 | $3,977 | $43 |
| Crestor | 29 | $3,842 | $132 |
| Proair Hfa | 59 | $3,702 | $63 |
| Metoprolol | 66 | $3,561 | $54 |
| Namenda Xr | 23 | $3,507 | $152 |
| Novolog | 21 | $3,492 | $166 |
| Nexium | 13 | $3,313 | $255 |
| Clotrimazole-Betamethasone | 63 | $3,269 | $52 |
| Valsartan-Hydrochlorothiazide | 37 | $2,950 | $80 |
| Ceftriaxone | 38 | $2,858 | $75 |
| Amlodipine Besylate | 195 | $2,488 | $13 |
| Pradaxa | 13 | $2,416 | $186 |
| Simvastatin | 214 | $2,364 | $11 |
| Lisinopril | 224 | $2,331 | $10 |
| Hydrocodone-Acetaminophen | 121 | $2,198 | $18 |
| Bystolic | 14 | $2,178 | $156 |
| Potassium Chloride | 78 | $2,154 | $28 |
| Levothyroxine | 173 | $2,144 | $12 |
| Lidocaine | 14 | $2,096 | $150 |
| Oxybutynin Chloride Er | 39 | $2,069 | $53 |
| Pioglitazone | 26 | $1,997 | $77 |
| Estrace | 13 | $1,991 | $153 |
| Betamethasone Dipropionate | 22 | $1,865 | $85 |
| Omeprazole | 80 | $1,730 | $22 |
| Oxycodone Hcl-Acetaminophen | 16 | $1,589 | $99 |
| Metformin | 137 | $1,535 | $11 |
| Metoprolol | 187 | $1,531 | $8 |
| Pioglitazone-Metformin | 13 | $1,486 | $114 |
| Escitalopram | 51 | $1,441 | $28 |
| Sertraline | 130 | $1,380 | $11 |
| Furosemide | 217 | $1,372 | $6 |
| Zolpidem | 74 | $1,366 | $18 |
| Montelukast | 19 | $1,327 | $70 |
| Isosorbide Mononitrate Er | 75 | $1,248 | $17 |
| Cilostazol | 53 | $1,235 | $23 |
| Tamsulosin | 43 | $1,174 | $27 |
| Warfarin | 136 | $1,171 | $9 |
| Fentanyl | 14 | $1,116 | $80 |
| Amlodipine Besylate-Benazepril | 38 | $1,108 | $29 |
| Lansoprazole | 13 | $1,099 | $85 |
| Carvedilol | 32 | $1,086 | $34 |
| Levetiracetam | 29 | $1,070 | $37 |
| Ropinirole | 45 | $1,063 | $24 |
| Ventolin Hfa | 25 | $1,060 | $42 |
| Felodipine Er | 29 | $1,045 | $36 |
| Glipizide | 102 | $1,024 | $10 |
| Gabapentin | 95 | $1,001 | $11 |
| Klor-Con M20 | 57 | $995 | $17 |
| Azelastine | 12 | $945 | $79 |
| Pantoprazole | 26 | $936 | $36 |
| Colestipol | 21 | $884 | $42 |
| Alendronate | 49 | $854 | $17 |
| Atenolol | 117 | $846 | $7 |
| Verapamil Er | 30 | $830 | $28 |
| Bd Ultra-Fine Pen Needle | 17 | $801 | $47 |
| Dipyridamole | 39 | $792 | $20 |
| Tramadol | 50 | $785 | $16 |
| Lovaza | 13 | $744 | $57 |
| Ranitidine | 56 | $742 | $13 |
| Metolazone | 32 | $738 | $23 |
| Amox Tr-Potassium Clavulanate | 17 | $737 | $43 |
| Famotidine | 65 | $722 | $11 |
| Risperidone | 41 | $718 | $18 |
| Hydrochlorothiazide | 97 | $717 | $7 |
| Probenecid | 17 | $716 | $42 |
| Glimepiride | 41 | $665 | $16 |
| Lovastatin | 61 | $643 | $11 |
| Alprazolam | 83 | $615 | $7 |
| Coumadin | 13 | $587 | $45 |
| Losartan | 40 | $579 | $14 |
| Venlafaxine Hcl Er | 16 | $573 | $36 |
| Sucralfate | 26 | $560 | $22 |
| Lisinopril-Hydrochlorothiazide | 30 | $535 | $18 |
| Finasteride | 23 | $531 | $23 |
| Meloxicam | 57 | $498 | $9 |
| Silver Sulfadiazine | 22 | $497 | $23 |
| Gentamicin Sulfate | 22 | $490 | $22 |
| Pravastatin | 33 | $490 | $15 |
| Levofloxacin | 25 | $481 | $19 |
| Cefadroxil | 23 | $458 | $20 |
| Lorazepam | 55 | $448 | $8 |
| Enulose | 35 | $441 | $13 |
| Cyclobenzaprine | 33 | $420 | $13 |
| Mupirocin | 18 | $415 | $23 |
| Meclizine | 16 | $411 | $26 |
| Losartan-Hydrochlorothiazide | 19 | $369 | $19 |
| Bumetanide | 43 | $360 | $8 |
| Isosorbide Dinitrate | 21 | $347 | $17 |
| Baclofen | 30 | $339 | $11 |
| Carisoprodol | 13 | $317 | $24 |
| Terbinafine | 17 | $280 | $16 |
| Triamcinolone Acetonide | 12 | $271 | $23 |
| Klor-Con 8 | 11 | $269 | $24 |
| Polyethylene Glycol 3350 | 15 | $269 | $18 |
| Nystatin | 23 | $266 | $12 |
| Ssd | 13 | $252 | $19 |
| Citalopram Hbr | 31 | $236 | $8 |
| Nystop | 12 | $228 | $19 |
| Tramadol Hcl-Acetaminophen | 12 | $226 | $19 |
| Clonazepam | 36 | $213 | $6 |
| Sulfamethoxazole-Trimethoprim | 33 | $210 | $6 |
| Ciprofloxacin | 30 | $197 | $7 |
| Azathioprine | 11 | $194 | $18 |
| Azithromycin | 14 | $193 | $14 |
| Sodium Chloride | 25 | $185 | $7 |
| Lidocaine | 13 | $184 | $14 |
| Bisoprolol-Hydrochlorothiazide | 18 | $174 | $10 |
| Clonidine | 12 | $169 | $14 |
| Metformin Hcl Er | 21 | $169 | $8 |
| Mirtazapine | 14 | $152 | $11 |
| Prednisone | 41 | $150 | $4 |
| Metoclopramide | 11 | $143 | $13 |
| Fluconazole | 13 | $140 | $11 |
| Amitriptyline | 24 | $133 | $6 |
| Chlordiazepoxide | 13 | $117 | $9 |
| Metronidazole | 11 | $117 | $11 |
| Spironolactone | 12 | $96 | $8 |
| Cephalexin | 12 | $92 | $8 |
| Trazodone | 13 | $82 | $6 |
| Temazepam | 14 | $71 | $5 |
| Diazepam | 18 | $37 | $2 |
Money from drug and device companies
$25 in 2025
| 2025 | 1 | 1 | None | $25 |
| 2022 | 3 | 5 | None | $662 |
| 2021 | 1 | 1 | None | $402 |
| 2020 | 1 | 2 | None | $106 |
| 2019 | 4 | 10 | None | $405 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Velsipity | $25 | 1 payment
|
See the published payment
| Pfizer | Meals · 2025-12-19 | Velsipity | $25 |
See earlier years (2022, 2021, 2020, 2019)
2022: $662
| Musculoskeletal Transplant Foundation | None | $537 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $96 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $29 | 1 payment
|
2021: $402
| Musculoskeletal Transplant Foundation | None | $402 | 1 payment
|
2020: $106
| Musculoskeletal Transplant Foundation | None | $106 | 2 payments
|
2019: $405
| Musculoskeletal Transplant Foundation | None | $301 | 7 payments
|
| Akcea Therapeutics | Tegsedi | $72 | 1 payment
|
| Tetraphase Pharmaceuticals | Xerava | $19 | 1 payment
|
| Astellas Pharma US | Lexiscan | $12 | 1 payment
|
Professional record
- NPI
- 1447291182
- Licence
- IL 036092912Illinois 036092912: Not Renewed
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- IL 036092912, IN 200109230A
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 270 Prairie Way, CA, Livermore, CA, 94550
- NPI first listed
- 2006-06-10
- NPI last updated
- 2025-03-29
- NPI record certified
- 2025-03-29
This is when the NPI record was last certified, not a medical board exam.